D.A. Davidson & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Sell
5,782
-51
-0.9% -$24.5K 0.02% 615
2026
Q1
$2.87M Buy
5,833
+596
+11% +$323K 0.02% 570
2025
Q4
$3.04M Buy
5,237
+375
+8% +$212K 0.02% 534
2025
Q3
$2.36M Buy
4,862
+192
+4% +$89.4K 0.02% 596
2025
Q2
$1.89M Sell
4,670
-3,960
-46% -$1.66M 0.01% 627
2025
Q1
$4.29M Sell
8,630
-110
-1% -$59.6K 0.03% 359
2024
Q4
$4.55M Sell
8,740
-1,418
-14% -$780K 0.04% 339
2024
Q3
$6.28M Buy
10,158
+201
+2% +$119K 0.05% 269
2024
Q2
$5.51M Buy
9,957
+395
+4% +$226K 0.05% 280
2024
Q1
$5.56M Buy
9,562
+239
+3% +$134K 0.05% 281
2023
Q4
$4.95M Sell
9,323
-572
-6% -$277K 0.05% 291
2023
Q3
$5.01M Sell
9,895
-632
-6% -$337K 0.05% 264
2023
Q2
$5.49M Sell
10,527
-7
-0.1% -$3.78K 0.06% 253
2023
Q1
$6.03M Sell
10,534
-2
-0% -$1.13K 0.07% 231
2022
Q4
$5.82M Sell
10,536
-30
-0.3% -$15.9K 0.07% 231
2022
Q3
$5.39M Sell
10,566
-100
-0.9% -$56K 0.07% 212
2022
Q2
$5.79M Sell
10,666
-177
-2% -$97.4K 0.07% 216
2022
Q1
$6.41M Buy
10,843
+14
+0.1% +$8.04K 0.07% 222
2021
Q4
$7.22M Buy
10,829
+2
+0% +$1.25K 0.08% 204
2021
Q3
$6.19M Sell
10,827
-164
-1% -$90K 0.07% 224
2021
Q2
$5.54M Sell
10,991
-336
-3% -$159K 0.07% 240
2021
Q1
$5.17M Sell
11,327
-1,292
-10% -$617K 0.07% 224
2020
Q4
$5.86M Sell
12,619
-68
-0.5% -$31.9K 0.09% 164
2020
Q3
$5.6M Sell
12,687
-163
-1% -$67.3K 0.1% 150
2020
Q2
$4.66M Sell
12,850
-3,377
-21% -$1.13M 0.09% 168
2020
Q1
$4.61M Sell
16,227
-249
-2% -$78.5K 0.09% 174
2019
Q4
$5.35M Buy
16,476
+1,626
+11% +$493K 0.09% 180
2019
Q3
$4.33M Sell
14,850
-1,419
-9% -$406K 0.08% 202
2019
Q2
$4.78M Sell
16,269
-13,860
-46% -$3.82M 0.09% 172
2019
Q1
$7.54M Sell
30,129
-1,090
-3% -$271K 0.13% 131
2018
Q4
$6.99M Sell
31,219
-488
-2% -$114K 0.14% 121
2018
Q3
$7.74M Sell
31,707
-4,560
-13% -$1.05M 0.14% 126
2018
Q2
$7.51M Buy
36,267
+969
+3% +$206K 0.15% 119
2018
Q1
$7.29M Buy
35,298
+315
+0.9% +$66.1K 0.15% 119
2017
Q4
$6.64M Buy
34,983
+178
+0.5% +$34.1K 0.14% 128
2017
Q3
$6.58M Sell
34,805
-155
-0.4% -$28.1K 0.13% 162
2017
Q2
$6.1M Sell
34,960
-94
-0.3% -$15.8K 0.14% 139
2017
Q1
$5.38M Sell
35,054
-30,693
-47% -$4.69M 0.13% 142
2016
Q4
$9.27M Buy
65,747
+8,307
+14% +$1.22M 0.21% 97
2016
Q3
$9.13M Buy
57,440
+15,406
+37% +$2.37M 0.23% 90
2016
Q2
$6.21M Buy
42,034
+597
+1% +$88.1K 0.18% 111
2016
Q1
$5.87M Buy
41,437
+1,647
+4% +$221K 0.18% 113
2015
Q4
$5.64M Buy
39,790
+245
+0.6% +$32.7K 0.18% 117
2015
Q3
$4.83M Buy
39,545
+458
+1% +$59.7K 0.17% 130
2015
Q2
$5.07M Sell
39,087
-575
-1% -$75K 0.17% 127
2015
Q1
$5.32M Buy
39,662
+23
+0.1% +$2.96K 0.17% 123
2014
Q4
$4.96M Buy
39,639
+5,509
+16% +$670K 0.16% 123
2014
Q3
$4.15M Buy
34,130
+217
+0.6% +$26.4K 0.14% 138
2014
Q2
$4M Sell
33,913
-1,304
-4% -$153K 0.14% 144
2014
Q1
$4.23M Sell
35,217
-626
-2% -$74.4K 0.15% 134
2013
Q4
$3.99M Sell
35,843
-972
-3% -$96.7K 0.15% 133
2013
Q3
$3.39M Buy
36,815
+922
+3% +$83.4K 0.15% 135
2013
Q2
$3.04M Buy
+35,893
New +$2.99M 0.15% 138

Other funds holding TMO

D.A. Davidson & Co's TMO Position: Q2 2026 in Review

D.A. Davidson & Co reduced its Thermo Fisher Scientific (TMO) stake by 0.87% in Q2 2026, selling an estimated $24.5K and leaving 5,782 shares worth $2.9M. The position accounts for 0.02% of the portfolio, ranked #615.

D.A. Davidson & Co first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.27M in Q4 2016. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • D.A. Davidson & Co held 5,782 shares of Thermo Fisher Scientific worth $2.9M as of Q2 2026.
  • D.A. Davidson & Co sold 51 Thermo Fisher Scientific shares in Q2 2026, an estimated $24.5K.
  • Thermo Fisher Scientific made up 0.02% of D.A. Davidson & Co's portfolio in Q2 2026, its #615 holding.
  • D.A. Davidson & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • D.A. Davidson & Co's Thermo Fisher Scientific position peaked at $9.27M in Q4 2016.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.